Close Menu

In the Pipeline's Derek Lowe talks about the occasional "perverse incentives" in oncology drug development. Lowe references an article from 2007 in the Journal of Clinical Oncology written by an investor, Tony Fiorino, who talks about the motives behind oncology research at large pharmaceutical companies versus small biotech start-ups.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Springer Nature announces €9,500 fee to make papers open-access in Nature and its family of journals.

Librarians have concluded that notebooks that belonged to Charles Darwin that were thought to have been lost were actually likely stolen, CNN reports.

An early SARS-CoV-2 alteration may have enabled it to spread more easily, according to the New York Times.

In PNAS this week: ultrarare variants contribute to aging-related hearing loss, telomeres of cells infected with herpesvirus, and more.